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RESEARCH ARTICLE

Open Access

Palatal mucosa derived fibroblasts present an
adaptive behavior regarding cytokine secretion
when grafted onto the gingival margin
Fabíola Pontes Azevedo1, Ana Carolina Faria Morandini2, Carla Renata Sipert2, Thiago José Dionísio2,
Carlos Ferreira Santos2*, Carla Andreotti Damante1, Maria Lúcia Rubo de Rezende1,
Adriana Campos Passanezi Sant’Ana1 and Sebastião Luiz Aguiar Greghi1

Abstract
Background: Considering that grafted gingival tissue might have to be adapted to the receptor area and that
fibroblasts have the ability to respond to bacterial stimuli through the release of various cytokines, this study
investigated whether fibroblasts from the palatal mucosa behave differently when grafted onto the gingival margin
regarding cytokine secretion.
Methods: Biopsies from the palatal mucosa were collected at the time of free gingival graft surgery, and after four
months re-collection was performed upon surgery for root coverage. Fibroblasts were isolated by the explant technique,
cultured and stimulated with Porphyromonas gingivalis (Pg) and Escherichia coli (Ec) LPS for 24 or 48 h for comparative
evaluation of the secretion of cytokines and chemokines, such as IL-6, IL-8/CXCL8, MIP-1α/CCL3, TGF-β, VEGF and CXCL16.
Unstimulated cells were used as the control group. Cells were tested for viability through MTT assay, and secretion of
cytokines and chemokines was evaluated in the cell supernatants by Enzyme-Linked Immunosorbent Assay (ELISA).
Results: Fibroblasts from the palatal mucosa maintained the same secretion pattern of IL-6 when grafted onto the
gingival margin. On the contrary, fibroblasts from the marginal gingival graft showed increased secretion of IL-8/CXCL8
even in the absence of stimulation. Interestingly, MIP-1α/CCL3 secretion by fibroblasts from the marginal gingival graft
was significantly increased after 48 hours of stimulation with Pg LPS and after 24 h with Ec LPS. Only fibroblasts from the
marginal gingival graft showed secretion of TGF-β. VEGF and CXCL16 secretion were not detected by both subsets of
fibroblasts.
Conclusion: Fibroblasts from the palatal mucosa seem to be adapted to local conditions of the site microenvironment
when grafted onto the gingival marginal area. This evidence supports the effective participation of fibroblasts in the
homeostasis of the marginal periodontium through secretion modulation of important inflammatory mediators.
Keywords: Periodontitis, Gingival fibroblasts, Cytokines, Chemokine, Inflammation

Background
Gingival tissue exposure to bacterial plaque can result in
tissue inflammation with clinical signs of color change,
size, shape, consistency and bleeding with the possibility
of alveolar bone loss due to periodontal disease progression [1]. The cumulative effect and repetitive pathological
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events to gingival tissue can lead to the occurrence and
progression of gingival recession, especially in cases with
narrow band or absence of attached gingiva [2-4].
According to the American Academy of Periodontology,
periodontal plastic surgery may be indicated to increase
the gingival width, creating a deeper vestibule in sites with
abnormal frenum attachment and inadequate attached
gingiva [5]. Even though the keratinized mucosa width
and gingiva are genetically determined, they can be affected by the presence of bacterial plaque associated with
inflammation or by mechanical interventions [6].
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It has been shown that fibroblasts, besides being the
most important cells in the maintenance and remodeling
of connective tissue extracellular matrix, are involved in
immune and inflammatory host response in periodontal
disease, as they are the predominant structural cells found
in periodontal infections by anaerobic bacteria such as
Porphyromonas gingivalis (Pg) and can be stimulated to
release inflammatory cytokines upon Pg and its subproducts challenge [7-11]. Besides being sensitive to their own
cytokines and growth factors, they can directly interact
with bacteria and their virulence factors, including lipopolysaccharide (LPS) in periodontal lesions [12].
Regarding gingival fibroblasts role in response to Pg LPS
through cytokines release, it was previously demonstrated
that these cells show differential behavior from periodontal ligament from the same donors, confirming the individuality of the anatomical region in determining the cell
response [9]. Specifically, for IL-6 and IL-8/CXCL8, a
well-known chemokine required for neutrophils recruitment, it was reported that these cells are able to secrete
huge amounts when stimulated by Pg LPS [8,13-15]. Additionally, gingival fibroblasts also secrete the chemokine
MIP-1α/CCL3 implying on monocytes chemoattraction in
periodontal disease [16] as well as TGF-β that induces the
expression of pro-collagen type I [17]. VEGF is another
cytokine related to the etiology of periodontal disease due
to the ability to increase vascular permeability that contributes to the dissemination of inflammation, allowing inflammatory mediator release by cells in the inflamed
tissue and enabling the formation of new blood vessels
[18]. Also, the chemokine CXCL16 is induced by other cytokines promoting gingival fibroblasts proliferation and
leukocyte migration into inflamed tissues helping the periodontal tissues reshuffle [19,20]. To the best of our knowledge, no previous work has addressed the secretion profile
of the aforementioned cytokines comparing the fibroblasts
from palatal mucosa (usually used as an autogenous donor
site for gingival graft procedures) with cells originated from
marginal gingival area.
Grafted gingival tissue might have to be adapted to the
receptor area and there is a large body of evidence that gingival fibroblasts are able to react to several stimuli through
cytokines and chemokines release, which in turn play an
important role in inflammatory response. Therefore, this
study aimed to investigate whether the secretion of cytokines and chemokines including repair mediators by human gingival fibroblasts would be modulated when grafted
from the palatal mucosa onto the gingival marginal area in
a free gingival graft procedure.

Methods
Sample collection and fibroblasts primary culture

After approval by the Institutional Review Board of the
Bauru School of Dentistry, University of São Paulo, #055/
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2011, three systemically and periodontally healthy individuals (28, 38 and 50 years-old, 3 females) were selected in
Periodontics Clinics, all of whom needed root coverage in
areas with scarce keratinized mucosa. They had no signs
of gingival inflammation, no bleeding on probing or critical
probing depth. All individuals were submitted to anamnesis, periodontal clinical examination and radiographic
exams. The inclusion criteria were individuals with deficient
keratinized mucosa, both in quantity and quality, without
systemic complications that could contraindicate the surgical procedures, and that provided written informed consent
to participate in the study.
The palatal mucosa specimens, sized 3x3 mm, were immediately obtained when an epithelium-connective tissue
graft was removed from the palatal donor site on the premolars area during free gingival graft surgery [21]. After
four months, specimens from gingival graft were obtained
from the marginal area, during a second surgical procedure for root coverage. Fibroblasts were isolated by the explant technique as previously described [8-11]. Briefly, the
specimens were processed immediately in Dulbecco's
modified Eagle's medium (DMEM; Invitrogen Life Technologies, Carlsbad, CA, USA) supplemented with 20% fetal
bovine serum (FBS; Gibco, Invitrogen Life Technologies,
Carlsbad, CA, USA). The epithelial layer was removed and
the specimens were minced as small as possible. Tissue
fragments of palatal mucosa or gingival graft were plated
separately in Petri dishes and covered with DMEM supplemented with 20% FBS and antibiotics (600 μL/mL penicillin, 300 μL/mL gentamicin sulfate and 100 μL/mL
amphotericin B). The explants were placed in 25 cm2
flasks and incubated at 37°C in a humidified atmosphere
of 5% CO2. The medium (DMEM 10% FBS) was changed every 2–3 days and cultures were maintained until
fibroblasts reached confluence. After confluence, the fibroblasts were harvested and used between the fourth
and eighth passages [8-11].
Fibroblasts stimulation

The cells were seeded in 24 well plates at a density of
2×104 cells/well and incubated at 37°C in a humidified atmosphere of 5% CO2 during 18 hours in DMEM 1% FBS.
After overnight adhesion, DMEM containing 1 μg/mL of
Pg LPS (Invivogen, San Diego, CA, USA) or Ec LPS (Invivogen) was added to the wells for 24 or 48 h. Non-stimulated
cells were used as controls. Both Pg LPS and Ec LPS were
ultrapure and purchased from Invivogen.
Phenotypic characterization of fibroblasts

Cells cultured from the palatal mucosa and gingival graft
were characterized as fibroblasts by their morphology and
staining with fibroblast surface protein (FSP; ab 11333,
Abcam, Cambridge, UK) by means of immunostaining
[11]. Cells were seeded in an 8-well plate with 1×104 cells
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per well and incubated at 37°C with 5% CO2 during
18 hours to adhere in subconfluence. Subsequently, the
wells were divided into groups (control, Pg LPS, Ec LPS
and negative control, which was performed without the
primary antibody) in duplicate, to cell stimulation. Cells
were fixed with paraformaldehyde 4% (15 min) and were
washed 3 times with 1x PBS and incubated with PBS BSA
3% (30 min at room temperature) followed by primary
monoclonal antibody incubation to fibroblast surface
marker diluted at 1:100 (2 μg/mL final concentration), and
finally with fluorescein-conjugated secondary antibody
(1:400) (Abcam) at 37°C in the dark for 1 hour. Coverslips
were mounted with mounting medium VECTASHIELD
Hard-Set Mounting Medium containing 49,6-diamidino-2-Phenylindole (DAPI; H-1500, Vector Laboratories, Burlingame, CA, USA) and analyzed by confocal
microscope laser scanning (TCS model, SPE, Leica
Mannheim, Germany).
Cell viability

Cell viability was analyzed from enzymatic activity with a
colorimetric assay MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide]. Briefly, cells were washed
with 1× PBS to remove culture medium and MTT (5 mg/
mL) was added to the groups (control, Pg LPS and Ec
LPS) or cell-free wells (blank). The plate was incubated
during 4 hours at 37°C with 5% CO2. After incubation, the
plate was centrifuged (200 g during 7 minutes at 21°C) and
MTT solution was removed to add dimethylsulfoxide
(DMSO; Sigma-Aldrich, St. Louis, MO). The optical density of the wells was determined using a plate reader (Fluostar Optima, BMG Labtech, Ortenberg, Germany) in the
wavelength of 570 nm.
Enzyme-linked immunosorbent assay (ELISA)

ELISA was performed following the manufacturer’s instructions to determine the protein levels of IL-6 (R&D
System, Minneapolis, MN, EUA), IL-8/CXCL8 (R&D System, Minneapolis, MN, EUA), MIP-1α/CCL3 (R&D System, Minneapolis, MN, EUA), TGF-β (eBioscience, San
Diego, CA, USA), VEGF (PeproTech, London, UK) and
CXCL16 (PeproTech, London, UK). Briefly, plates of 96
wells were incubated with capture antibody anti-IL-6, IL-8/
CXCL8, MIP-1α/CCL3, TGF-β, VEGF or CXCL16 diluted
in 1x PBS buffer. After blocking for 1 hour to avoid nonspecific binding, 100 μl of standard IL-6, IL-8/CXCL8,
MIP-1α/CCL3, TGF-β, VEGF and CXCL16 and culture supernatants were placed. The cytokines were detected by
horseradish peroxidase-labeled monoclonal antibody to
each target after addition of 100 μl anti-human IL-6, IL-8/
CXCL8, MIP-1α/CCL3, TGF-β, VEGF and CXCL16 biotinylated antibodies were placed in each well and incubated
for 2 hours at room temperature. The microplate was
washed to remove unbound enzyme-labeled antibodies.
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The amount of horseradish peroxidase bound to each well
was determined by the addition of 100 μl substrate solution.
The reaction was stopped by the addition of 100 μl of 1 M
sulfuric acid, and the plates were read at 450 nm (Synergy™
MX Monochromator Based Multi-Mode Microplate Reader,
BioTek Instruments, Inc, Winooski, VT, USA). The concentrations of IL-6, IL-8/CXCL8, MIP-1α/CCL3, TGF-β, VEGF
and CXCL16 were determined by interpolation from a
standard curve and presented as pg/mL for duplicate assays
of duplicate samples of each of the tested conditions.
Statistical analysis

Comparisons for viability through MTT among samples
were performed using One-way ANOVA test followed by
Tukey test. ELISA data normality was verified by the
Kolmogorov-Smirnov method. The statistical differences
were determined by three-way ANOVA followed by Tukey
test. Statistical analyses were performed with STATISTICA
(version 11.0; StatSoft Inc). P values < 0.05 were considered
significant. The results were expressed as mean and one
standard deviation of the mean.

Results
Phenotypic characterization of fibroblasts

Cellular staining with a fibroblast surface marker (FSP)
was performed to confirm the fibroblastic phenotype. Fibroblasts were analyzed by immunofluorescence in all
groups (control, Pg LPS, Ec LPS and negative control).
Positive staining was observed for all groups (Figure 1), with
Pg LPS (Figure 1C) and Ec LPS (Figure 1B) groups being
slightly higher. For the negative control group (Figure 1D),
which did not receive primary antibody, no signal was detected. This result confirms the characterization of the cultured cells as fibroblasts.
Cell viability

Cell viability was evaluated after 24 and 48 h, in the control (non-stimulated) and testing groups (stimulated
with Pg LPS and Ec LPS). There was no difference in
cells viability with the stimuli used after 24 and 48 h
(Figure 2).
Cytokines secretion comparing fibroblasts from the
palatal mucosa with the marginal gingival grafted cells

When the targets of this study were compared between
the two subpopulations of fibroblasts, IL-6 secretion was
statistically significant after 24 and 48 h of Pg LPS stimulation (Figure 3A and B) by both subtypes of fibroblasts
(from the palatal mucosa and gingival graft in marginal
area), and the difference was greater with 48 h (Figure 3B).
On the other hand, the secretion after Ec LPS stimulation
was only statistically significant after 48 h, by both subtypes
of fibroblasts (Figure 3D). Additionally, IL-6 secretion was
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Figure 1 Cells characterization by fibroblast protein surface staining. Cultured cells were immunostained for fibroblast surface protein (FSP)
and analyzed by a confocal microscope at an increase of 63x. (A) control; (B) stimulated by Ec LPS; (C) stimulated by Pg LPS and (D) negative
control, labeled nuclei in blue (DAPI).

Figure 2 Cells viability. Fibroblasts viability challenged with Pg LPS and Ec LPS evaluated at 24 and 48 hours in the control (non-stimulated) and
test groups (stimulated with Pg LPS and Ec LPS) through MTT assay.
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Figure 3 IL-6 secretion by human fibroblasts cultured from palatal mucosa and marginal gingival graft. A-D: primary cell cultures were
obtained from periodontal tissues from three healthy subjects and, after the fourth passage, were stimulated with LPS from P. gingivalis and from
E. coli in a concentration of 1 μg/mL. Culture medium without stimuli was used as the control. ELISA was performed for the quantification of the
cytokines on the cell culture supernatants. Representative figure of the average of three independent experiments, n = 3. *P < 0.05 was
considered significantly different. PMF = palatine mucosa fibroblasts. GMF = marginal gingival fibroblasts.

greater by non-stimulated fibroblasts from the marginal
gingival graft (Figure 3).
Fibroblasts from the palatal mucosa secreted more IL-8/
CXCL8 than fibroblasts from the marginal gingival graft
when stimulated by Pg LPS with a statistically significant
difference at 48 h (Figure 4A and B). Also, regarding this
chemokine, fibroblasts from the palatal mucosa showed
an increase at both 24 h and 48 h when stimulated by Ec
LPS (Figure 4C and D), which was not observed by cells
from the marginal gingival graft.
In this study, MIP-1α/CCL3 was observed to be constitutively secreted by both fibroblasts subtypes (Figure 5).
Moreover, there was no statistically significant difference
in MIP-1α/CCL3 secretion between unstimulated fibroblasts (control group) and fibroblasts stimulated with Pg
or Ec LPS from the palatal mucosa (Figure 5). However,
statistically significant difference was observed in MIP-1α/
CCL3 secretion after 48 h when fibroblasts from the marginal gingival graft were stimulated with Pg LPS (Figure 5B)
and after 24 h when challenged by Ec LPS (Figure 5C).
When TGF-β secretion was evaluated, fibroblasts from
the palatal mucosa showed no detectable levels even in

the presence of Pg LPS (Figure 6A and B) or Ec LPS
(Figure 6C and D). On the contrary, fibroblasts from the
marginal gingival graft showed a constitutive TGF-β secretion and there was no statistically significant difference between stimulated and unstimulated cells, both at
24 h and 48 h (Figure 6). VEGF and CXCL16 secretion
was not detected either on fibroblasts supernatant cultured from the palatal mucosa neither from the marginal
gingival tissue, regardless stimulation by Pg or Ec LPS.

Discussion
Fibroblasts are not a unique cell group across the different
anatomical regions [9,22-24]. They are the predominant
cells in periodontal connective tissue [12], and are involved
in the host immune response by releasing inflammatory cytokines [7] and repair mediators [25,26]. To the best of the
author’s knowledge, this is the first study to investigate and
compare the profile of mediators secretion by human fibroblasts cultured from non-marginal palatal mucosa with the
marginal gingival grafted tissue, indicating the differences
or similarities between these cells in contributing for cytokines secretion upon bacterial LPS stimulation.
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Figure 4 IL-8/CXCL8 secretion by human fibroblasts cultured from palatal mucosa and marginal gingival graft. A-D: primary cell cultures
were obtained from periodontal tissues from three healthy subjects and, after the fourth passage, were stimulated with LPS from P. gingivalis and
from E. coli in a concentration of 1 μg/mL. Culture medium without stimuli was used as the control. ELISA was performed for the quantification
of the cytokines on the cell culture supernatants. Representative figure of the average of three independent experiments, n = 3. *P < 0.05 was
considered significantly different. PMF = palatine mucosa fibroblasts. GMF = marginal gingival fibroblasts.

In the present study, it was observed that both fibroblasts derived from palatal mucosa and marginal gingival
graft secreted IL-6 cytokine similarly when stimulated by
Pg or Ec LPS. We recognize that it would have been valuable to investigate mRNA expression in order to better
understand whether transcript levels would be different
between them. This could give us some information about
possible post transcriptional modifications that can alter
production of cytokines. Previous studies [8,14,15,27,28]
have shown that fibroblasts exposed to bacterial stimuli
such as LPS showed significant IL-6 expression, indicating
the importance of this cytokine in the host immune and
inflammatory response in periodontitis, but the present investigation also revealed increased IL-6 secretion at 48 h
for both subtypes of fibroblasts. Here, there was IL-6 constitutive secretion by unstimulated cells from the palatal
mucosa and also from the marginal gingival graft, being
statistically significant for the latter. Scheres et al. [14]
showed that non-stimulated gingival fibroblasts expressed
and secreted more IL-6 than periodontal ligament fibroblasts. This suggested that gingival fibroblasts have a
higher state of activity because they are more susceptible
to have contact with periodontal pathogens and here we

highlight this important role for both subtypes of gingival
cells.
It is shown here that fibroblasts from the palatal mucosa
only secreted IL-8/CXCL8 chemokine when stimulated
with bacterial LPS. When these cells were grafted onto the
gingival marginal area, after 4 months IL-8/CXCL8 chemokine secretion was observed even in the absence of
LPS stimuli. This change in the expression profile may be
related to the closer contact of the cells with bacterial
virulence factors, such as Pg LPS, on the marginal periodontium. Previous studies [9,13-15,29] have shown that
fibroblasts stimulated by Pg LPS are able to produce IL-8,
and fibroblasts from different anatomical regions show
heterogeneity on chemokine profile secretion [14]. Therefore, it further emphasizes that the heterogeneous secretion of IL-8/CXCL8 in the current study may have
occurred by the environmental influence on the secretion
of fibroblast mediators grafted onto a new anatomical region, in which there is adaptation and proliferation of
these cells.
When the chemokine MIP-1α/CCL3 was investigated, it
was observed that when fibroblasts from the palatal mucosa were grafted onto the marginal gingival area, they
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Figure 5 MIP-1α/CCL3 secretion by human fibroblasts cultured from palatal mucosa and marginal gingival graft. A-D: primary cell
cultures were obtained from periodontal tissues from three healthy subjects and, after the fourth passage, were stimulated with LPS from P.
gingivalis and from E. coli in a concentration of 1 μg/mL. Culture medium without stimuli was used as the control. ELISA was performed for the
quantification of the cytokines on the cell culture supernatants. Representative figure of the average of three independent experiments, n = 3.
*P < 0.05 was considered significantly different. PMF = palatine mucosa fibroblasts. GMF = marginal gingival fibroblasts.

maintained similar cytokine constitutive secretion in the
absence of bacterial stimulation. However, fibroblasts from
the marginal gingival graft showed a higher secretion compared with fibroblasts from the palatal mucosa only after
48 h when stimulated by Pg LPS, showing a timedependent expression. Again, the increased chemokine secretion, in this case MIP-1α/CCL3, by fibroblasts from the
marginal gingival graft might have occurred due to prior
stimulation in the marginal area by dental plaque in the sulcus, suggesting that these cells present an adaptive behavior
when grafted onto the gingival margin. A previous work by
our group [9] showed that gingival and periodontal ligament fibroblasts behaved differently on MIP-1α/CCL3 secretion when stimulated by Pg LPS, and also showed an
increased MIP-1α/CCL3 secretion when cells were challenged by Pg LPS in low concentrations such as 0.1 μg/mL,
which increased over time.
Concerning TGF-β secretion, fibroblasts cultured
from the palatal mucosa and from the marginal gingival
graft showed a heterogeneous behavior. Fibroblasts
from the palatal mucosa did not show TGF-β secretion

even against the bacterial stimuli applied. On the contrary,
fibroblasts from the marginal gingival graft secreted TGFβ, without any difference between stimulated and nonstimulated cells. One study [30] showed that fibroblasts
from periodontal ligament expressed TGF-β but its production was not affected by bacterial LPS, suggesting
that TGF-β accumulate in inflammatory conditions suppressing the cellular immune function, yet without leading to tissue destruction through stimulation with
bacterial LPS. Another study comparing periodontal
ligament and gingival cells [8] found that TGF-β secretion depended on the stimulus concentration, mainly
for gingival fibroblasts, being higher when challenged
with 10 μg/mL of LPS, whereas the concentration of
1 μg/mL as used in the current study, showed no significant differences compared with the non-stimulated
fibroblasts. The increased TGF-β secretion found here
by marginal grafted cells could be related to tissue repair and might have occurred by the continuous repair
need, since the constant presence of dental sulcus
microbiota induces marginal changes.
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Figure 6 TGF-β secretion by human fibroblasts cultured from palatal mucosa and marginal gingival graft. A-D: primary cell cultures were
obtained from periodontal tissues from three healthy subjects and, after the fourth passage, were stimulated with LPS from P. gingivalis and from
E. coli in a concentration of 1 μg/mL. Culture medium without stimuli was used as the control. ELISA was performed for the quantification of the
cytokines on the cell culture supernatants. Representative figure of the average of three independent experiments, n = 3. *P < 0.05 was considered
significantly different. PMF = palatine mucosa fibroblasts. GMF = marginal gingival fibroblasts.

Lastly, the results indicated that neither fibroblasts
from the palatal mucosa nor from the marginal gingival
graft secreted VEGF nor CXCL16, according to the
stimuli used. Previous studies [31,32] have shown that
human gingival fibroblasts stimulated by LPS, vesicle
and proteins from Pg and Aa extracellular membrane
were able to produce VEGF when stimulated by such
agents. Maybe in this study the time and concentration
of LPS used were not sufficient for the induction of
VEGF. Regarding CXCL16, it was reported that this
expression was induced by other cytokines such as IFNγ and TNF-α, and their secretion was mediated by ADAM
10 membrane receptor, which regulates CXCL16 function on inflamed tissues [33]. Another work [19]
showed that CXCL16 expression by gingival fibroblasts
was controlled by several cytokines such as IL-1β, TNFα and IFN- γ. In fact, one could speculate that CXCL16
secretion was not detected in the current study because
fibroblasts were stimulated only by bacterial LPS, and
the action of other cytokines or other stimuli might be
necessary for secretion of CXCL16 by gingival fibroblasts [19,33].

The heterogeneous secretion of inflammatory and repair
mediators may indicate that fibroblasts grafted onto a new
anatomical region (gingival margin) may be influenced by
the microenvironment at the moment these cells are in
contact with bacterial products, participating more effectively in the context of the inflammatory response.

Conclusions
Fibroblasts from the palatal mucosa present an adaptive
behavior regarding cytokines secretion when grafted onto
the gingival margin, showing difference in the secretion of
important inflammatory mediators to the marginal periodontium homeostasis.
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